ASSOCIATION BETWEEN IMPROVEMENT IN ENTHESOPATHY AND QUALITY OF LIFE: RESULTS FROM ANTI TNF-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS IN TWO PHASE 3 USTEKINUMAB TRIALS

McInnes I. B.; Puig L.; Gottlieb A. B.; Ritchlin C.; You Y.; Song M.; Kafka S.; Tang K. L.; Morgan G. J.; Rahman P.; Kavanaugh A.

首页> 外文期刊>Clinical and experimental rheumatology >ASSOCIATION BETWEEN IMPROVEMENT IN ENTHESOPATHY AND QUALITY OF LIFE: RESULTS FROM ANTI TNF-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS IN TWO PHASE 3 USTEKINUMAB TRIALS

【24h】

ASSOCIATION BETWEEN IMPROVEMENT IN ENTHESOPATHY AND QUALITY OF LIFE: RESULTS FROM ANTI TNF-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS IN TWO PHASE 3 USTEKINUMAB TRIALS

机译：改善患者的肠胃病状态和生活质量之间的关系：两个阶段性USTEKINUMAB试验中，未使用TNF的抗风湿性关节炎患者合并风湿性关节炎

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical and experimental rheumatology》 |2016年第4期|共1页
作者
McInnes I. B.; Puig L.; Gottlieb A. B.; Ritchlin C.; You Y.; Song M.; Kafka S.; Tang K. L.; Morgan G. J.; Rahman P.; Kavanaugh A.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. ASSOCIATION BETWEEN IMPROVEMENT IN ENTHESOPATHY AND QUALITY OF LIFE: RESULTS FROM ANTI TNF-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS IN TWO PHASE 3 USTEKINUMAB TRIALS [J] . McInnes I. B., Puig L., Gottlieb A. B., Clinical and experimental rheumatology . 2016,第4期

机译：改善患者的肠胃病状态和生活质量之间的关系：两个阶段性USTEKINUMAB试验中，未使用TNF的抗风湿性关节炎患者合并风湿性关节炎
2. Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trial. [J] . Kavanaugh A, Menter A, Mendelsohn A, Current medical research and opinion . 2010,第10期

机译：ustekinumab对银屑病关节炎患者的身体功能和健康相关生活质量的影响：一项随机，安慰剂对照的II期临床试验。
3. Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebocontrolled, randomised PSUMMIT 2 trial [J] . RitchlinC., RahmanP., KavanaughA., Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2014,第6期

机译：抗IL-12/23 p40单克隆抗体，Ustekinumab，在患有常规非生物和生物抗肿瘤坏死因子治疗的患者中，抗IL-12/23 p40单克隆抗体，Ustekinumab的功效和安全性：6个月和1年的第3阶段结果，多中心，双盲，安放的，随机的psummit 2试验
4. Psoriatic arthritis Clinical improvement and correlation with hormone axes in etanercept-treated patients [C] . Fabiola Atzeni, Rainer H. Straub, Maurizio Cutolo, International Conference on the Neuroendocrine Immune Basis of the Rheumatic Diseases . 2010

机译：依托西普治疗患者患者临床改善及与激素轴相关性
5. Improving Preoperative Education for Patients Receiving Thumb Basal Joint Arthritis Surgery: A Quality Improvement Project [D] . Switlick, Marilda Nava. 2018

机译：改善拇指基底关节关节炎手术患者的术前教育：一项质量改进项目
6. Extended report: Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody ustekinumab in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3 multicentre double-blind placebo-controlled randomised PSUMMIT 2 trial [O] . Christopher Ritchlin, Proton Rahman, Arthur Kavanaugh, -1

机译：扩展报告：抗IL-12 / 23 p40单克隆抗体ustekinumab在活动性银屑病关节炎患者中的疗效和安全性尽管采用传统的非生物和生物抗肿瘤坏死因子疗法：6个月和1年的结果3期多中心双盲安慰剂对照随机PSUMMIT 2试验
7. PMS12 USTEKINUMAB RESULTS: IN RAPID, SUSTAINED AND CLINICALLY MEANINGFUL IMPROVEMENTS IN PHYSICAL DISABILITY AND QUALITY OF LIFE IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS: FROM A RANDOMIZED AND PLACEBO-CONTROLLED PHASE II TRIAL [O] . Kavanaugh A, Menter A, Han C, 2009

机译：PMS12 USTEKINUMAB结果：对快速性，持续性和临床意义的改善性关节炎患者的身体残疾和生活质量的改善：结果：来自随机控制的第二阶段试验

ASSOCIATION BETWEEN IMPROVEMENT IN ENTHESOPATHY AND QUALITY OF LIFE: RESULTS FROM ANTI TNF-NAIVE PATIENTS WITH PSORIATIC ARTHRITIS IN TWO PHASE 3 USTEKINUMAB TRIALS

著录项

相似文献

相关主题

期刊订阅